LYTS vs. AQST
LYTS (LSI Industries Inc.) and AQST (Aquestive Therapeutics, Inc.) are both stocks. LYTS operates in Electronic Components (Technology), while AQST operates in Drug Manufacturers - Specialty & Generic (Healthcare). Over the past 5 years, LYTS returned 29.98%/yr vs 1.23%/yr for AQST. At a 0.18 correlation, their price movements are largely independent.
Performance
LYTS vs. AQST - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, LYTS achieves a 42.76% return, which is significantly higher than AQST's -26.93% return.
LYTS
- 1D
- -2.11%
- 1M
- 11.95%
- YTD
- 42.76%
- 6M
- 39.78%
- 1Y
- 62.54%
- 3Y*
- 29.73%
- 5Y*
- 29.98%
- 10Y*
- 11.87%
AQST
- 1D
- 0.21%
- 1M
- 14.56%
- YTD
- -26.93%
- 6M
- -20.81%
- 1Y
- 45.23%
- 3Y*
- 37.14%
- 5Y*
- 1.23%
- 10Y*
- —
LYTS vs. AQST - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
LYTS LSI Industries Inc. | 42.76% | -4.68% | 39.69% | 16.79% | 82.88% | -17.98% | 45.70% | 100.79% | -35.66% |
AQST Aquestive Therapeutics, Inc. | -26.93% | 81.46% | 76.24% | 123.92% | -76.81% | -27.29% | -8.08% | -7.62% | -58.14% |
Correlation
The correlation between LYTS and AQST is 0.16, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.16 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.16 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.13 |
Correlation (All Time) Calculated using the full available price history since Jul 25, 2018 | 0.18 |
Fundamentals
LYTS:
$843.36M
AQST:
$578.72M
LYTS:
$0.76
AQST:
-$0.61
LYTS:
1.35
AQST:
10.67
LYTS:
$609.84M
AQST:
$50.27M
LYTS:
$156.38M
AQST:
$20.92M
LYTS:
$39.60M
AQST:
-$53.08M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
LYTS vs. AQST — Risk / Return Rank
LYTS
AQST
LYTS vs. AQST - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for LSI Industries Inc. (LYTS) and Aquestive Therapeutics, Inc. (AQST). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| LYTS | AQST | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.99 | ||
| Sortino ratioReturn per unit of downside risk | +1.01 | ||
| Omega ratioGain probability vs. loss probability | 1.30 | 1.21 | +0.09 |
| Calmar ratioReturn relative to maximum drawdown | 2.29 | 0.75 | +1.54 |
| Martin ratioReturn relative to average drawdown | 5.13 | 1.40 | +3.74 |
Loading charts...
Drawdowns
LYTS vs. AQST - Drawdown Comparison
The maximum LYTS drawdown since its inception was -85.55%, smaller than the maximum AQST drawdown of -96.68%. Use the drawdown chart below to compare losses from any high point for LYTS and AQST.
Loading charts...
Drawdown Indicators
| LYTS | AQST | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -85.55% | -96.68% | +11.13% |
Max Drawdown (1Y)Largest decline over 1 year | -27.42% | -60.61% | +33.19% |
Max Drawdown (3Y)Largest decline over 3 years | -40.60% | -63.55% | +22.95% |
Max Drawdown (5Y)Largest decline over 5 years | -40.60% | -90.11% | +49.51% |
Max Drawdown (10Y)Largest decline over 10 years | -76.17% | — | — |
Current DrawdownCurrent decline from peak | -2.11% | -75.11% | +73.00% |
Average DrawdownAverage peak-to-trough decline | -38.19% | -76.92% | +38.73% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 12.22% | 32.48% | -20.26% |
Volatility
LYTS vs. AQST - Volatility Comparison
LSI Industries Inc. (LYTS) and Aquestive Therapeutics, Inc. (AQST) have volatilities of 12.58% and 12.13%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| LYTS | AQST | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 12.58% | 12.13% | +0.45% |
Volatility (6M)Calculated over the trailing 6-month period | 29.21% | 68.58% | -39.37% |
Volatility (1Y)Calculated over the trailing 1-year period | 41.17% | 85.05% | -43.88% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 43.89% | 82.71% | -38.82% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 48.12% | 87.62% | -39.50% |
Dividends
LYTS vs. AQST - Dividend Comparison
LYTS's dividend yield for the trailing twelve months is around 0.77%, while AQST has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AQST Aquestive Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
LYTS LSI Industries Inc. | 0.77% | 1.09% | 1.03% | 1.42% | 1.63% | 2.92% | 2.34% | 3.31% | 6.31% | 2.91% | 2.05% | 0.98% |
Financials
LYTS vs. AQST - Financials Comparison
This section allows you to compare key financial metrics between LSI Industries Inc. and Aquestive Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
LYTS vs. AQST - Profitability Comparison
LYTS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, LSI Industries Inc. reported a gross profit of 39.72M and revenue of 150.53M. Therefore, the gross margin over that period was 26.4%.
AQST - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Aquestive Therapeutics, Inc. reported a gross profit of 0.00 and revenue of 14.45M. Therefore, the gross margin over that period was 0.0%.
LYTS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, LSI Industries Inc. reported an operating income of 3.81M and revenue of 150.53M, resulting in an operating margin of 2.5%.
AQST - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Aquestive Therapeutics, Inc. reported an operating income of -4.20M and revenue of 14.45M, resulting in an operating margin of -29.1%.
LYTS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, LSI Industries Inc. reported a net income of 2.09M and revenue of 150.53M, resulting in a net margin of 1.4%.
AQST - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Aquestive Therapeutics, Inc. reported a net income of -8.06M and revenue of 14.45M, resulting in a net margin of -55.8%.
Frequently Asked Questions
LYTS and AQST have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
LYTS has higher volatility (12.58%) compared to AQST (12.13%). In terms of maximum drawdown, LYTS dropped -85.55% vs AQST's -96.68%.
LYTS currently has the higher Sharpe Ratio (1.53 vs 0.54), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for LYTS and AQST
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer